Research Articles | Page 26 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
How I Treat Paroxysmal nocturnal hemoglobinuria Jan 2021 Blood Paroxysmal Nocturnal Hemoglobinuria (PNH)
SF3B1-mutant myelodysplastic syndrome as a distinct disease subtype - A Proposal of the International Working Group for the Prognosis of Myelodysplastic Syndromes (IWG-PM) Apr 2020 Blood Myelodysplastic Syndromes (MDS)
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia Jun 2023 Blood Aplastic Anemia
Newly revised 2023 MDS response criteria Apr 2023 Blood Myelodysplastic Syndromes (MDS)
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes Apr 2023 Blood Myelodysplastic Syndromes (MDS)
Germline DDX41 mutations define a significant entity within adult MDS/AML patients Sep 2019 Blood Myelodysplastic Syndromes (MDS)
The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes Jan 2019 Blood Myelodysplastic Syndromes (MDS)
Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria May 2020 Blood Aplastic Anemia, Myelodysplastic Syndromes (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes Sep 2020 Blood Myelodysplastic Syndromes (MDS)
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings Apr 2023 Blood Myelodysplastic Syndromes (MDS)